• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

VVUS:US

5.3600 USD 0.1100 2.10%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Vivus Inc (VVUS)

Open: 5.2600 Day's Range: 5.1300 - 5.3600 Volume: 2,245,028
Previous Close: 5.2500 52wk Range: 4.7100 - 15.6200 1-Yr Rtn: -55.07%

Stock Chart for VVUS

No chart data available.
  • VVUS:US 5.3600
  • 1D
  • 1M
  • 1Y
5.2500
Interactive VVUS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VVUS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.5627
Est. EPS (USD) (12/2014) -1.6090
Est. PEG Ratio -
Market Cap (M USD) 553.70
Shares Outstanding (M) 103.30
30 Day Average Volume 3,200,746
Price/Book (mrq) 3.6053
Price/Sale (ttm) 6.7214
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VVUS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VVUS

VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.

Seth H Z FischerCEO/Chief Commercial OfficerSvai SanfordInterim CFO
Lee B PerryVP/Chief Acctg Ofcr/Assistant SecyJohn L SlebirSenior VP:Bus Dev/Secy
More Company Profile & Key Executives for VVUS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil